Latest filing published 25 Sept 2026 for Iradimed CORP.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -23.5%Entry US$164.55 · Close at T+365 US$125.94
- +12.4%Entry US$18.69 · Close at T+365 US$21.01
- +0.3%Entry US$20.66 · Close at T+365 US$20.72
- -1.2%Entry US$24.11 · Close at T+365 US$23.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joe E. Kiani: trading record in brief
Joe E. Kiani (chief executive) discloses dealings in 4 companies, chiefly Masimo Corp, Stereotaxis, Inc. and Saba Software Inc. We count 210 filings; the first trade dates from 16 January 2007 and the latest from 23 September 2026.
Market trades split into 18 purchases (€9.0M) and 104 sales (€468.8M). Netting one side against the other leaves €459.8M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 19 share grants and 66 option exercises.
Half of the purchases are above €322k and half below. Across 14 purchases, this insider has always bought alone, with no colleague buying within 30 days. After 4 purchases with a full 90-day history, the hit rate stands at 75% and the median 90-day move at +7.1%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 25 September 2026: an option exercise, in Iradimed Corp. The clock since the last published purchase (30 May 2023) now reads 1,258 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joe E. Kiani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 698 sharesCommon StockSEC:0001228621-26-000003:0
- 231,748 shares@ US$37.8429.8% of flowCommon StockSEC:0000937556-24-000067:0
- 3,929 shares@ US$128.700.1% of flowCommon StockSEC:0001104659-24-030167:1
- 10,050 shares0Common StockSEC:0001104659-24-030167:0
- 500 shares@ US$158.190.0% of flowCommon StockSEC:0000937556-23-000110:2Canonical exit: 23 Aug 2023 (T+90)
- 2,265 shares@ US$157.530.1% of flowCommon StockSEC:0000937556-23-000110:1Canonical exit: 23 Aug 2023 (T+90)
- 3,600 shares@ US$156.78742.0% of flowCommon StockSEC:0000937556-23-000110:0Canonical exit: 23 Aug 2023 (T+90)
- 42,735 shares0Common StockSEC:0000937556-23-000030:1
- 42,735 shares0Common StockSEC:0000937556-23-000030:0
- 26,410 shares@ US$182.430.9% of flowCommon StockSEC:0000937556-23-000028:1
- 50,161 shares0Common StockSEC:0000937556-23-000028:0
- 48,982 shares0Common StockSEC:0000937556-23-000006:0
- 2,397 shares@ US$144.190.1% of flowCommon StockSEC:0000937556-22-000151:1Canonical exit: 15 Mar 2023 (T+90)
- 2,039 shares@ US$145.220.1% of flowCommon StockSEC:0000937556-22-000151:2Canonical exit: 15 Mar 2023 (T+90)
- 1,541 shares@ US$146.230.0% of flowCommon StockSEC:0000937556-22-000151:3Canonical exit: 15 Mar 2023 (T+90)
- 1,063 shares@ US$143.27370.5% of flowCommon StockSEC:0000937556-22-000151:0Canonical exit: 15 Mar 2023 (T+90)
- 16,537 shares@ US$124.450.4% of flowCommon StockSEC:0000937556-22-000144:1Canonical exit: 12 Feb 2023 (T+90)
- 300 shares@ US$124.990.0% of flowCommon StockSEC:0000937556-22-000144:2Canonical exit: 12 Feb 2023 (T+90)
- 2,969 shares@ US$128.860.1% of flowCommon StockSEC:0000937556-22-000142:1Canonical exit: 9 Feb 2023 (T+90)
- 2,514 shares@ US$129.900.1% of flowCommon StockSEC:0000937556-22-000142:2Canonical exit: 9 Feb 2023 (T+90)
- 1,100 shares@ US$130.560.0% of flowCommon StockSEC:0000937556-22-000142:3Canonical exit: 9 Feb 2023 (T+90)
- 1,201 shares@ US$127.79680.6% of flowCommon StockSEC:0000937556-22-000142:0Canonical exit: 9 Feb 2023 (T+90)
- 15,157 shares@ US$123.47836.7% of flowCommon StockSEC:0000937556-22-000144:0Canonical exit: 12 Feb 2023 (T+90)
- 93,032 shares0Common StockSEC:0000937556-22-000053:0
- 10,561 shares@ US$292.780.5% of flowCommon StockSEC:0000937556-22-000002:1
25 of 210 declarations